Purpose Fixation stability (FS) of the preferred retinal locus (PRL) may be improved by biofeedback fixation training (BFT) with microperimetry. Such training can be done on the patient's PRL or in different retinal loci with better functional characteristics. We studied both options and compared the outcomes. Methods Sixty-seven consecutive patients with bilateral central vision loss, poor FS and visual acuity (VA) lower than 0.3 LogMAR were recruited for BFT with microperimeter. Patients were assigned into 2 groups. In group A, BFT was performed on the patient's spontaneous PRL. In group B, PRL was located between 2 adjacent loci with the highest light sensitivity and the lowest distance from the fovea. Two sets of 12 weekly BFT sessions were performed. Primary outcomes were: FS, VA and reading speed. Results Outcomes were statistically significantly better in group B. Mean percentage of FS at therapy end improved from 32 to 35% for group A and from 40 to 55% in group B. Mean VA improved from 1 to 0.86 in group A and from 1 to 0.84 in group B. Reading speed (wpm) improved from 56 to 58 in group A and from 63 to 89 in group B. Conclusions This study describes a reliable methodology of improving eccentric fixation stability using BFT in microperimetry, when the fixation training locus is individualized as the retinal area with best functional characteristics. Further studies are needed to validate its value in a larger scale of patients, at different stages of the disease, and its persistence over time.

PurposeThe purpose of this study was to establish a normal reference database for fixation stability measured with the bivariate contour ellipse area (BCEA) in the Macular Integrity Assessment (MAIA) microperimeter.MethodsSubjects were 358 healthy volunteers who had the MAIA examination. Fixation stability was assessed using two BCEA fixation indices (63% and 95% proportional values) and the percentage of fixation points within 1° and 2° from the fovea (P1 and P2). Statistical analysis was performed with linear regression and Pearson's product moment correlation coefficient.ResultsAverage areas of 0.80 deg2 (min = 0.03, max = 3.90, SD = 0.68) for the index BCEA@63% and 2.40 deg2 (min = 0.20, max = 11.70, SD = 2.04) for the index BCEA@95% were found. The average values of P1 and P2 were 95% (min = 76, max = 100, SD = 5.31) and 99% (min = 91, max = 100, SD = 1.42), respectively. The Pearson's product moment test showed an almost perfect correlation index, r = 0.999, between BCEA@63% and BCEA@95%. Index P1 showed a very strong correlation with BCEA@63%, r = −0.924, as well as with BCEA@95%, r = −0.925. Index P2 demonstrated a slightly lower correlation with both BCEA@63% and BCEA@95%, r = −0.874 and −0.875, respectively.ConclusionsThe single parameter of the BCEA@95% may be taken as accurately reporting fixation stability and serves as a reference database of normal subjects with a cutoff area of 2.40 ± 2.04 deg2 in MAIA microperimeter.Translational RelevanceFixation stability can be measured with different indices. This study originates reference fixation values for the MAIA using a single fixation index.

Low vision patients with eccentric viewing (EV) use extrafoveal retinal areas to compensate for the loss of central vision. Such retinal loci are known as the preferred retinal locus (PRL). It is known that EV is accompanied by unstable fixation. Microperimetry systems with biofeedback training have been used as a rehabilitation aid to improve fixation stability in EV patients. Normally, only the best or dominant eye is selected for such rehabilitation. This case report describes the rehabilitation on both eyes by means of PRL relocation with MAIA microperimetry (Centervue, Padova, Italy) with biofeedback training technology of a 74-year-old woman diagnosed with adult pseudovitelliform dystrophy. The patient presented binocularly similar anatomical and functional characteristics with the PRL located over the dystrophic area. At the end of the 3 months rehabilitation period, the PRL was successfully relocated inferiorly from the fovea showing relevant visual acuity improvement.

No abstract

Delayed cerebral vasospasm following subarachnoid hemorrhage (SAH) is a serious medical complication, characterized by constriction of cerebral arteries leading to varying degrees of cerebral ischemia. Numerous clinical and experimental studies have been performed in the last decades; however, the pathophysiologic mechanism of cerebral vasospasm after SAH still remains unclear. Among a variety of experimental SAH models, the double hemorrhage rat model involving direct injection of autologous arterial blood into the cisterna magna has been used most frequently for the study of delayed cerebral vasospasm following SAH in last years. Despite the simplicity of the technique, the second blood injection into the cisterna magna may result in brainstem injury leading to high mortality. Therefore, a modified double hemorrhage model of cisterna magna has been developed in rat recently. We describe here step by step the surgical technique to induce double SAH and compare the degree of vasospasm with other cisterna magna rat models using histological assessment of the diameter and cross-sectional area of the basilar artery.

This case illustrates the importance of electrophysiological investigation in early VAD-related retinopathy detection correlated with microperimetry. Our findings indicate a more delayed central cone function recovery than that of generalised rod and cone function. There was a marked correlation between ERG and microperimetric changes.

To evaluate the incidence of symptomatic anisometropia and aniseikonia requiring intervention following surgery with combined pars plana vitrectomy (PPV) and broad 276 style encircling scleral buckle (ESB) for the repair of rhegmatogenous retinal detachments (RRD) and to report axial length (AL) and keratometry changes, a retrospective review of consecutive RRD patients treated with combined PPV and ESB between June 2016 until September 2019 was performed. All patients with symptomatic optically induced aniseikonia requiring additional interventions or surgical procedures including clear lens exchanges, secondary intraocular lens implants or contact lenses were documented. Keratometry and AL measurements were recorded for each eye and changes calculated. In total, 100 patients underwent combined PPV, ESB and endotamponade with mean age of 59.47 years (SD 11.49). AL was significantly increased (25.39 mm [SD 1.27] to 26.54 mm [SD 1.16], p = 0.0001), with a mean change of 1.15 mm (SD 0.67). Mean corneal astigmatism increased by –0.95 D (SD 0.51) in control eyes preoperatively and –1.33 (SD 0.87) postoperatively (p = 0.03). Over half of phakic patients (39/61; 64%) developed a visually significant cataract, subsequently undergoing surgery. Six of 100 patients developed symptomatic anisometropia with aniseikonia postoperatively (6%). Four proceeded with clear lens exchange despite absence of visually significant cataract (4%). Two of these initially trialled contact lenses (2%). One was intolerant, while the other decided to proceed with clear lens exchange for convenience. Only one patient (1%), being pseudophakic in both eyes, had persistent anisometropia/aniseikonia. AL and keratometry changes induced by encirclement with broad solid silicone rubber buckles are acceptable and similar to those reported previously using narrow encircling components, being unlikely to induce troublesome symptomatic anisometropia/aniseikonia. Many patients are phakic and develop visually significant cataracts, allowing correction of changes induced with the aim of visual restoration. A minority require more prolonged methods of visual rehabilitation, such as contact lens wear or clear lens exchanges. Caution and appropriate consent should be made in patients that are pseudophakic in both eyes at presentation.

This study aims to evaluate the ability of MAIA MP in detecting early changes in retinal function not only with the analysis of retinal sensitivity, but also with the analysis of fixation behaviour in eyes with diabetic macular oedema, and investigate their correlation with central macular thickness measured with OCT and visual acuity (LogMAR) at baseline and in 3 months from commencing treatment intravitreal anti-VEGF therapies. 23 consecutive patients with clinically significant diabetic macular oedema presenting to the practice of the University Hospital, Queen's Medical Centre, Nottingham, were recruited into this study. The morphological changes and VA data in our cohort confirm the clinical efficacy of treatments of DMO with intravitreal injections of ranibizumab. The morphological changes of macular thickness, intraretinal cysts or subretinal fluid (SRF) on OCT decreased in all internal subfields at 3 months with treatment compared to baseline values. The measurement of visual function with MP may be considered as an important tool to better diagnose retinal pathologies as part of multimodality imaging, responding to the need to combine morpho-functional information, and combining different images from different measurement technologies.